The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / October / Could Wearables Redefine Diagnostics?
Analytical science Biochemistry and molecular biology Point of care testing Technology and innovation Molecular Pathology

Could Wearables Redefine Diagnostics?

Advances in biosensors and manufacturing could bring continuous molecular monitoring into routine care, but clinical validation remains a major challenge

10/23/2026 News 2 min read
  • Full Article
  • Summary
  • Listen
  • Scorecard
  • Quiz
  • Poll

Share

Clinical Scorecard: Could Wearables Redefine Diagnostics?

At a Glance

CategoryDetail
ConditionWearable diagnostic technologies for monitoring molecular biomarkers and physiological signals
Key MechanismsWearable sensors measure biomarkers in fluids such as sweat, tears, and saliva, as well as electrical activity, movement, and cardiovascular function; AI may identify patterns across measurements.
Target PopulationPeople being assessed or monitored for conditions including diabetes, cardiovascular disease, neurological disorders, cancer, and inflammatory conditions.
Care SettingEveryday-life monitoring and potential clinical assessment; the review describes technologies that require further validation before broad clinical adoption.

Key Highlights

  • Wearable devices can track biological changes continuously, unlike tests that provide measurements at specific time points.
  • Platforms include skin patches, smart contact lenses, and electronic textiles.
  • Sensors can measure metabolites, electrolytes, hormones, and physiological signals.
  • Movement, environmental conditions, individual differences, and performance deterioration can affect measurement reliability.
  • The authors state that wearable diagnostics should complement, not replace, conventional testing.

Guideline-Based Recommendations

Diagnosis

  • Do not infer clinical equivalence from analytical sensitivity alone.
  • Compare wearable technologies with established diagnostic methods, including laboratory assays, imaging, and histopathology.

Management

  • Use wearable diagnostics as complementary to conventional testing, according to the authors.
  • Further investigate how biomarker concentrations in sweat and other fluids translate into clinically meaningful results.

Monitoring & Follow-up

  • Assess sensor reliability during prolonged use and under varying movement and environmental conditions.
  • Evaluate measurement reliability across individuals.

Risks

  • Sensor performance may deteriorate during prolonged use.
  • Movement, environmental conditions, and individual differences may affect measurement reliability.
  • Many wearable technologies have not been adequately compared with established diagnostic methods.

Patient & Prescribing Data

The review discusses potential applications across diabetes, cardiovascular disease, neurological disorders, cancer, and inflammatory conditions; it provides no prescribing criteria.

Wearable glucose sensors are described as widely used and as demonstrating the clinical value of continuous biochemical monitoring. Other wearable diagnostic applications remain under development or require further validation.

Clinical Best Practices

  • Require standardized validation, reliable long-term performance, and regulatory oversight before clinical translation.
  • Compare wearable measurements with established diagnostic methods.
  • Treat wearable diagnostics as complementary to conventional testing rather than as replacements.

Related Resources & Content

  • Review published in Nano-Micro Letters (title and URL not provided in the source)

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.